Comparing two anti-fungal drug combination in the treatment of fungal infection.
Not Applicable
Completed
- Conditions
- Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/11/059827
- Lead Sponsor
- meenakshi medical college hospital and research institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1) Patient with diagnosis of tinea corporis and tinea cruris confirmed by KOH microscopy.
2)Patients for whom documented consent has been obtained regarding their voluntary participation in this clinical study.
3)Patients aged 18 years or older at the time that they provide consent.
4)Patient agrees not to take other treatments than those provided in the study.
Exclusion Criteria
1)Patient below 18 years of age.
2)Pregnant and lactating mothers.
3)Patient who are immunocompromised due to disease or drugs.
4)Patient with pre existing renal,hepatic diseases and cardiac failure.
5)Patient with history of hypersensitivity to itraconazole, terbinafine and ketoconazole
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients overall satisfaction from <br/ ><br>the condition <br/ ><br>Timepoint: baseline and at 4 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil